A CIRCULATING EXOSOMAL MICRORNA SIGNATURE FOR THE NONINVASIVE PREDICTION OF RESPONSE TO THE FIRST-LINE PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH METASTATIC GASTRIC CANCER

被引:0
|
作者
Okuno, Keisuke
Watanabe, Shuichi
Hur, Hoon
Lee, Jeeyun
Tokunaga, Masanori
Kinugasa, Yusuke
Goel, Ajay
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1125
引用
收藏
页码:S766 / S766
页数:1
相关论文
共 50 条
  • [1] A retrospective study of first-line platinum-based combination chemotherapy in patients with recurrent and advanced gastric cancer
    Lim, D.
    Lee, D.
    Park, D.
    Park, D.
    Park, D.
    Lim, D.
    Kang, D.
    EJC SUPPLEMENTS, 2009, 7 (02): : 371 - 371
  • [2] Maintenance chemotherapy is effective in patients with metastatic triple negative breast cancer after first-line platinum-based chemotherapy
    Chen, Yang
    Zhang, Jian
    Hu, Xi-Chun
    Wang, Bi-Yun
    Wang, Zhong-Hua
    Wang, Lei-Ping
    Cao, Jun
    Tao, Zhong-Hua
    Du, Yi-Qun
    Zhao, Yan-Nan
    Gong, Cheng-Cheng
    Jin, Jia
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (05) : 3018 - 3027
  • [3] Maintenance chemotherapy is effective in patients with metastatic triple negative breast cancer after first-line platinum-based chemotherapy
    Zhang, J.
    Chen, Y.
    Hu, X.
    ANNALS OF ONCOLOGY, 2019, 30 : 132 - 132
  • [4] An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer
    Cavalieri, Stefano
    Serafini, Mara Serena
    Carenzo, Andrea
    Canevari, Silvana
    Lenoci, Deborah
    Pistore, Federico
    Miceli, Rosalba
    Vecchio, Stefania
    Ferrari, Daris
    Moro, Cecilia
    Sponghini, Andrea
    Caldara, Alessia
    Rocca, Maria Cossu
    Secondino, Simona
    Moretti, Gabriella
    Denaro, Nerina
    Caponigro, Francesco
    Vaccher, Emanuela
    Rinaldi, Gaetana
    Ferrau, Francesco
    Bossi, Paolo
    Licitra, Lisa
    De Cecco, Loris
    CELLS, 2022, 11 (19)
  • [5] Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
    Grande, Enrique
    Bamias, Aristotelis
    Galsky, Matthew D.
    Kikuchi, Eiji
    Davis, Ian D.
    Arranz, Jose Angel
    Kalebasty, Arash Rezazadeh
    del Muro, Xavier Garcia
    Park, Se Hoon
    De Giorgi, Ugo
    Alekseev, Boris
    Mencinger, Marina
    Izumi, Kouji
    Puente, Javier
    Li, Jian-Ri
    Bernhard, Sandrine
    Nicholas, Alan
    Telliez, Julie
    De Santis, Maria
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 58 : 28 - 36
  • [6] Optimal Number of Cycles of First-line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
    Minato, Akinori
    Ohno, Daichi
    Murooka, Kazuki
    Okumura, Yutaka
    Takaba, Tomohisa
    Higashijima, Katsuyoshi
    Nagata, Yujiro
    Tomisaki, Ikko
    Harada, Kenichi
    Fujimoto, Naohiro
    IN VIVO, 2024, 38 (04): : 1927 - 1934
  • [7] NEOADJUVANT CHEMOTHERAPY MAY IMPAIR RESPONSE TO FIRST LINE PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN CANCER PATIENTS
    Ekmann-Gade, A. W.
    Hogdall, C.
    Peen, U. B. S.
    Engelholm, S. A.
    Fago-Olsen, C. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 675 - 676
  • [8] Survival Outcomes Following Combination of First-Line Platinum-Based Chemotherapy with S-1 in Patients with Advanced Gastric Cancer
    Koumarianou, Anna
    Ntavatzikos, Anastasios
    Vallilas, Christos
    Kampoli, Katerina
    Kakoseou, Zoi
    Karamouzis, Michalis, V
    CANCERS, 2020, 12 (12) : 1 - 12
  • [9] The prognostic impact of bone metastasis in patients with metastatic urothelial carcinoma treated with first-line platinum-based chemotherapy
    Alqaisi, Husam A.
    Stecca, Carlos
    Veitch, Zachary W.
    Riromar, Jamila
    Kaiser, Jeenan
    Fallah-Rad, Nazanin
    Jiang, Di Maria
    North, Scott
    Samnani, Sunil
    Alimohamed, Nimira
    Sridhar, Srikala S.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [10] FAN score predicts prognosis after platinum-based first-line chemotherapy in patients with metastatic urothelial carcinoma
    Ishizuya, Yu
    Kawashima, Atsunari
    Horibe, Yuki
    Yamamoto, Akinaru
    Tani, Masaru
    Yoshimura, Akihiro
    Yutong, Liu
    Nesrine, Sassi
    Oka, Toshiki
    Okuda, Yohei
    Uemura, Toshihiro
    Yamamichi, Gaku
    Hayashi, Takuji
    Yamamoto, Yoshiyuki
    Kato, Taigo
    Hatano, Koji
    Nonomura, Norio
    SCIENTIFIC REPORTS, 2025, 15 (01):